Preclinical relevance of dosing time for the therapeutic index of gemcitabine–cisplatin

Por Li, X M, Tanaka, K, Sun, J, Filipski, E, Kayitalire, L, Focan, C, Lévi, F
Publicado em 2005

Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial

Por Focan, C, Beauduin, M, Salamon, E, Greve, J de, Wasch, G de, Lobelle, J P, Majois, F, Tagnon, A, Tytgat, J, Belle, S van, Vandervellen, R, Vindevoghel, A
Publicado em 2001